Arthritis Care Res (Hoboken). 2021 Aug 26. doi: 10.1002/acr.24771. Online ahead of print.
ABSTRACT
We thank Li et al for their commentary on our recently published paper “Mortality in Ankylosing Spondylitis According to Treatment: A Nationwide Retrospective Cohort Study of 5900 Patients from Israel” (1). Their major concern was regarding the findings which demonstrated no excess mortality in ankylosing-spondylitis (AS) patients treated with TNF-inhibitors (TNFi).
PMID:34437772 | DOI:10.1002/acr.24771
